
suggest better use of existing drugs increases cervical cancer survival and reduces recurrence
byUniversity College LondonCredit: Unsplash/CC0 Public DomainThe INTERLACE phase III trial assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could redu
Updated on: October 23,2023
293

suggest better use of existing drugs increases cervical cancer survival and reduces recurrence
byUniversity College LondonCredit: Unsplash/CC0 Public DomainThe INTERLACE phase III trial assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could redu
Updated on:October 23,2023
293
